Reliability of point-of-care testing of INR in acute stroke

Can J Neurol Sci. 2008 Jul;35(3):348-51. doi: 10.1017/s0317167100008945.

Abstract

Background: In the emergency department, portable point-of-care testing (POCT) coagulation devices may facilitate stroke patient care by providing rapid International Normalized Ratio (INR) measurement. The objective of this study was to evaluate the reliability, validity, and impact on clinical decision-making of a POCT device for INR testing in the setting of acute ischemic stroke (AIS).

Methods: A total of 150 patients (50 healthy volunteers, 51 anticoagulated patients, 49 AIS patients) were assessed in a tertiary care facility. The INR's were measured using the Roche Coaguchek S and the standard laboratory technique.

Results: The interclass correlation coefficient and 95% confidence interval between overall POCT device and standard laboratory value INRs was high (0.932 (0.69 - 0.78). In the AIS group alone, the correlation coefficient and 95% CI was also high 0.937 (0.59 - 0.74) and diagnostic accuracy of the POCT device was 94%.

Conclusions: When used by a trained health professional in the emergency department to assess INR in acute ischemic stroke patients, the CoaguChek S is reliable and provides rapid results. However, as concordance with laboratory INR values decreases with higher INR values, it is recommended that with CoaguChek S INRs in the > 1.5 range, a standard laboratory measurement be used to confirm the results.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Acute Disease
  • Adult
  • Aged
  • Blood Coagulation / drug effects
  • Case-Control Studies
  • Cohort Studies
  • Female
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • International Normalized Ratio*
  • Male
  • Middle Aged
  • Point-of-Care Systems / statistics & numerical data*
  • Prospective Studies
  • Reference Values
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Statistics, Nonparametric
  • Stroke / drug therapy*
  • Thrombolytic Therapy / methods*

Substances

  • Fibrinolytic Agents